OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 12.213K |
Day Range | - - - |
52 Wk Range | 2.080 - 7.400 |
Market Cap | $24.617M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 4.07% |
Days to Cover | 35.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OncoCyte (NASDAQ: OCX) through any online brokerage.
Other companies in OncoCyte’s space includes: Galecto (NASDAQ:GLTO), Lumos Pharma (NASDAQ:LUMO), Sensei Biotherapeutics (NASDAQ:SNSE), Indaptus Therapeutics (NASDAQ:INDP) and Lisata Therapeutics (NASDAQ:LSTA).
The latest price target for OncoCyte (NASDAQ: OCX) was reported by Piper Sandler on Monday, November 13, 2023. The analyst firm set a price target for 3.00 expecting OCX to rise to within 12 months (a possible 0.67% upside). 6 analyst firms have reported ratings in the last year.
The stock price for OncoCyte (NASDAQ: OCX) is $2.98 last updated March 27, 2024 at 1:55 PM EDT.
There are no upcoming dividends for OncoCyte.
OncoCyte’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for OncoCyte.
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.